Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey in France

EBioMedicine

Volumn 2, Issue 8, 2015, Pages 891-897

  Verger, Pierre ^a,b,c,d   Fressard, Lisa ^a,b,c   Collange, Fanny ^a,b,c   Gautier, Arnaud ^e   Jestin, Christine ^e   Launay, Odile ^d,f   Raude, Jocelyn ^g   Pulcini, Céline ^h,i   Peretti Watel, Patrick ^a,b,c  

^a AIX MARSEILLE UNIV   (France)

^b OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d INSERM   (France)

^e Institut National de Prévention et d Education pour la Santé French National Institute for Prevention and Health Education   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g EHESP SCHOOL OF PUBLIC HEALTH   (France)

^h UNIVERSITÉ DE LORRAINE   (France)

ⁱ UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Adverse effects; Attitudes of health personnel; General practitioners; Private practice; Trust; Vaccine hesitancy

Indexed keywords

ADJUVANT VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; UNCLASSIFIED DRUG; VACCINE; WART VIRUS VACCINE;

ADULT; ALZHEIMER DISEASE; ARTICLE; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDY; DRUG EFFICACY; DRUG SAFETY; EPIDEMIC MENINGITIS; FEMALE; FRANCE; GENERAL PRACTITIONER; GUILLAIN BARRE SYNDROME; HEALTH PERSONNEL ATTITUDE; HEALTH SURVEY; HUMAN; IATROGENIC DISEASE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NARCOLEPSY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; VACCINATION; PREVALENCE; TREATMENT REFUSAL;

ADULT; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; TREATMENT REFUSAL; VACCINATION; VACCINES;

EID: 84951574125     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2015.06.018     Document Type: Article

References (47)

1. Allison P.D. Logistic Regression Using SAS: Theory and Application 2012, SAS Institute. Second Edition.
2. Bandura A. Self-efficacy. Encyclopedia of Human Behavior 1994, 71-81. New York. V.S. Ramachaudran (Ed.).
3. Bean S.J., Catania J.A. Vaccine perceptions among Oregon health care providers. Qual. Health Res. 2013, 23:1251-1266. 10.1177/1049732313501891.
4. Benin A.L., Wisler-Scher D.J., Colson E., Shapiro E.D., Holmboe E.S. Qualitative analysis of mothers' decision-making about vaccines for infants: the importance of trust. Pediatrics 2006, 117:1532-1541. 10.1542/peds.2005-1728.
5. Bish A., Yardley L., Nicoll A., Michie S. Factors associated with uptake of vaccination against pandemic influenza: a systematic review. Vaccine 2011, 29:6472-6484. 10.1016/j.vaccine.2011.06.107.
6. Bland J.M., Altman D.G. Statistics notes: Cronbach's alpha. Br. Med. J. 1997, 314:572.
7. Brien S., Kwong J.C., Buckeridge D.L. The determinants of 2009 pandemic A/H1N1 influenza vaccination: a systematic review. Vaccine 2012, 30:1255-1264. 10.1016/j.vaccine.2011.12.089.
8. Bruno D.M., Wilson T.E., Gany F., Aragones A. Identifying human papillomavirus vaccination practices among primary care providers of minority, low-income and immigrant patient populations. Vaccine 2014, 32:4149-4154. 10.1016/j.vaccine.2014.05.058.
9. Cabana M.D., Rand C.S., Powe N.R., Wu A.W., Wilson M.H. Why don't physicians follow a framework for improvement. JAMA 1999, 282:1458-1465.
10. Clerc I., Ventelou B., Guerville M.-A., Paraponaris A., Verger P. General practitioners and clinical practice guidelines: a reexamination. Med. Care Res. Rev. 2011, 68:504-518. 10.1177/1077558710397761.
11. Couette M., Boisse M.-F., Maison P., et al. Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction. J. Inorg. Biochem. 2009, 103:1571-1578. 10.1016/j.jinorgbio.2009.08.005.
12. Daley M.F., Crane L.A., Markowitz L.E., et al. Human papillomavirus vaccination practices: a survey of US physicians 18months after licensure. Pediatrics 2010, 126:425-433. 10.1542/peds.2009-3500.
13. Dubé E., Laberge C., Guay M., Bramadat P., Roy R., Bettinger J. Vaccine hesitancy: an overview. Hum. Vaccin. Immunother. 2013, 9:1763-1773. 10.4161/hv.24657.
14. Ecole des Hautes Etudes en Santé Publique. Faciliter l'accès aux vaccinations en s'appuyant sur les Agences Régionales de Santé 2013.
15. Edwards N., Kornacki M.J., Silversin J. Unhappy doctors: what are the causes and what can be done?. BMJ 2002, 324:835-838. 10.1136/bmj.324.7341.835.
16. European Centre for Disease Prevention and Control. Let's Talk About Protection 2012, ECDC, Stockholm, (http://ecdc.europa.eu/en/healthtopics/immunisation/comms-aid/Documents/Vaccine-comms-action-2013.pdf).
17. European Centre for Disease Prevention and Control Communication on Immunisation - Building Trust 2012, ECDC, Stockholm, (http://ecdc.europa.eu/en/publications/Publications/TER-Immunisation-and-trust.pdf).
18. Flicoteaux R., Pulcini C., Carrieri P., Schwarzinger M. Correlates of general practitioners' recommendations to patients regarding vaccination for the 2009-2010 pandemic influenza (A/H1N1) in France: implications for future vaccination campaigns. Vaccine 2014, 32:2281-2287. 10.1016/j.vaccine.2014.02.074.
19. François M., Alla F., Rabaud C., Raphaël F. Hepatitis B virus vaccination by French family physicians. Médecine Mal. Infect. 2011, 41:518-525. 10.1016/j.medmal.2011.07.002.
20. Freed G.L., Clark S.J., Cowan A.E., Coleman M.S. Primary care physician perspectives on providing adult vaccines. Vaccine 2011, 29:1850-1854. 10.1016/j.vaccine.2010.12.097.
21. Gherardi R.K., Coquet M., Chérin P., et al. Macrophagic myofasciitis: an emerging entity. Lancet 1998, 352:347-352. 10.1016/S0140-6736(98)02326-5.
22. Gherardi R.K., Coquet M., Cherin P., et al. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain 2001, 124:1821-1831. 10.1093/brain/124.9.1821.
23. Gowda C., Dempsey A.F. The rise (and fall?) of parental vaccine hesitancy. Hum. Vaccin Immunother. 2013, 9:1755-1762. 10.4161/hv.25085.
24. Greene W.H. Econometric Analysis 2003, Prentice Hall, Upper Saddle River, NJ. 5th ed.
25. Gust D.A., Darling N., Kennedy A., Schwartz B. Parents with doubts about vaccines: which vaccines and reasons why. Pediatrics 2008, 122:718-725. 10.1542/peds.2007-0538.
26. Haut Conseil de la Santé Publique Aluminium et vaccins http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=369.
27. Heckman J.J. Sample selection bias as a specification error. Econometrica 1979, 47:153-161.
28. Holman D.M., Benard V., Roland K.B., Watson M., Liddon N., Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014, 168:76-82. 10.1001/jamapediatrics.2013.2752.
29. Joyce C.M., Scott A., Jeon S.-H., et al. The 'medicine in Australia: balancing employment and life (MABEL)' longitudinal survey-protocol and baseline data for a prospective cohort study of Australian doctors' workforce participation. BMC Health Serv. Res. 2010, 10:50. 10.1186/1472-6963-10-50.
30. Larson H.J., Heymann D.L. Public health response to influenza A(H1N1) as an opportunity to build public trust. JAMA 2010, 303:271-272. 10.1001/jama.2009.2023.
31. Larson H.J., Cooper L.Z., Eskola J., Katz S.L., Ratzan S. Addressing the vaccine confidence gap. Lancet 2011, 378:526-535. 10.1016/S0140-6736(11)60678-8.
32. Larson H.J., Jarrett C., Eckersberger E., Smith D.M.D., Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. Vaccine 2014, 32:2150-2159. 10.1016/j.vaccine.2014.01.081.
33. Larson H.J., Smith D.M.D., Paterson P., et al. Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines. Lancet Infect. Dis. 2013, 13:606-613. 10.1016/S1473-3099(13)70108-7.
34. Llupià A., García-Basteiro A.L., Mena G., et al. Vaccination behaviour influences self-report of influenza vaccination status: a cross-sectional study among health care workers. PLoS ONE 2012, 7:1-5. 10.1371/journal.pone.0039496.
35. McRee A.-L., Gilkey M.B., Dempsey A.F. HPV vaccine hesitancy: findings from a statewide survey of health care providers. J. Pediatr. Health. Care 2014, 28:1-9. 10.1016/j.pedhc.2014.05.003.
36. Obrizan M. Essays on Selection in Health Survey Data 2010.
37. Peretti-Watel P., Larson H., Ward J., Schulz W., Verger P. Vaccine hesitancy: clarifying a theoretical framework for an ambiguous notion. PLoS Curr. Outbreaks 2015, 10.1371/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289.
38. Poland G.A. The 2009-2010 influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns. Vaccine 2010, 28(Suppl. 4):D3-D13. 10.1016/j.vaccine.2010.08.024.
39. Pulcini C., Massin S., Launay O., Verger P. Factors associated with vaccination for hepatitis B, pertussis, seasonal and pandemic influenza among French general practitioners: a 2010 survey. Vaccine 2013, 31:3943-3949. 10.1016/j.vaccine.2013.06.039.
40. Pulcini C., Massin S., Launay O., Verger P. Knowledge, attitudes, beliefs and practices of general practitioners towards measles and MMR vaccination in southeastern France in 2012. Clin. Microbiol. Infect. 2014, 20:38-43. 10.1111/1469-0691.12194.
41. Rogerson P. Statistical Methods for Geography 2001, SAGE.
42. SAGE Group http://www.who.int/immunization/sage/sage_wg_vaccine_hesitancy_apr12/en/.
43. Schwarzinger M., Verger P., Guerville M.-A., et al. Positive attitudes of French general practitioners towards A/H1N1 influenza-pandemic vaccination: a missed opportunity to increase vaccination uptakes in the general public?. Vaccine 2010, 28:2743-2748. 10.1016/j.vaccine.2010.01.027.
44. Tavakol M., Dennick R. Making sense of Cronbach's alpha. Int. J. Med.Educ. 2011, 2:53-55. 10.5116/ijme.4dfb.8dfd.
45. Verger P., Flicoteaux R.R., Schwarzinger M., et al. Pandemic influenza (A/H1N1) vaccine uptake among French private general practitioners: a cross sectional study in 2010. PLoS ONE 2012, 7:e41837. 10.1371/journal.pone.0041837.
46. Yaqub O., Castle-Clarke S., Sevdalis N., Chataway J. Attitudes to vaccination: a critical review. Soc. Sci. Med. 2014, 112C:1-11. 10.1016/j.socscimed.2014.04.018.
47. Zimmerman R.K., Santibanez T.A., Fine M.J., et al. Barriers and facilitators of pneumococcal vaccination among the elderly. Vaccine 2003, 21:1510-1517. 10.1016/S0264-410X(02)00698-9.